| Literature DB >> 34192068 |
Sisanda Gaga1, Nokuzola Mqoqi1, Raymond Chimatira2, Singilizwe Moko3, Jude O Igumbor4.
Abstract
BACKGROUND: Continuous quality improvement (CQI) is essential for HIV and tuberculosis (TB) services. Similarly, a thorough understanding of the requirements and impact of CQI is critical to its successful institutionalisation. However, this is currently lacking.Entities:
Keywords: HIV/AIDS; South Africa; continuous quality improvement; interventions; outcomes; services
Year: 2021 PMID: 34192068 PMCID: PMC8182456 DOI: 10.4102/sajhivmed.v22i1.1202
Source DB: PubMed Journal: South Afr J HIV Med ISSN: 1608-9693 Impact factor: 2.744
List of items used for quality of care audit.
| S/N | Items |
|---|---|
| 1 | Is baseline CD4 count recorded? |
| 2 | Is baseline WHO clinical stage recorded? |
| 3 | Is the patient’s WHO clinical stage recorded at the last visit? |
| 4 | Is the patient’s weight recorded at the last visit? |
| 5 | Is the patient eligible for CrAg test at ART initiation (CD4 < 100)? |
| 5.1 | If the patient is eligible, was CrAg performed before ART was initiated? |
| 6 | Is the patient on a TDF, AZT, LPV/r (Alluvia) or NVP-containing regimen? |
| 6.1 | If yes, is creatinine, HB, ALT, cholesterol or triglyceride done at baseline and at follow-up visits as per national guidelines? |
| 7 | Was the patient’s TB screening documented at the last visit? |
| 8 | Did the patient screen positive for any TB symptoms? |
| 8.1 | If the patient screened positive for TB symptoms, were appropriate investigations ordered for PTB or EPTB? |
| 9 | If the patient screened negative for any TB symptoms and is eligible for IPT, was the patient initiated on isoniazid? |
| 10 | Is the patient eligible for CPT, i.e. WHO 2, 3 or 4; and/or CD4 < 200? |
| 11 | If the patient is eligible, was cotrimoxazole (or with contra-indications, dapsone) initiated? |
| 12 | Is this patient still on ART after 6 months of ART initiation? |
| 13 | Are TB patients (new and relapsed) with an HIV status recorded ( |
| 14 | Is the HIV-positive TB patient |
| 15 | Is the HIV-positive TB patient |
| 16 | Is the HIV-positive TB patient started on ART? |
| 17 | Is the HIV-positive TB patient started on ART |
| Age – At first diagnosis | |
| DOB – At first diagnosis | |
| Sex – At first diagnosis | |
| 18 | Was the client diagnosed on GXP? |
| 19 | Is the GXP result received in less than 48 hours? |
| 20 | Is baseline smear AFB done for eligible client? |
| 21 | Is baseline smear AFB result TAT within or < 48 hours? |
| 22 | Is the TAT correctly documented in the case identification register? |
| 23 | Was the correct coding done according to the type of TB? |
| 24 | Is the patient appearing on the TB Diary? |
| 25 | Was the patient investigated at 7 weeks (smears for AFB taken)? |
| 26 | Did the patient smear convert at 7 weeks? |
| 27 | Was LPA done for non-converters? |
| 28 | Was the patient investigated at 11 weeks (smears for AFB taken)? |
| 29 | Was 2nd and/or 3rd smear taken? |
| 29.1 | If yes, are results recorded in the register? |
| 30 | Is the patient’s outcome recorded in the register? |
| 30.1 | Is the outcome correct? |
| 31 | Was TB contact identification and tracing done? |
| 31.1 | Were the contacts screened? |
| 31.2 | Was IPT offered to eligible contacts? |
| 32 | Is there a bin card for each item in the storeroom or electronic system (either)? |
| 33 | Is the information on the bin card maintained and updated for HIV and TB? |
| ARVs | |
| Co-trimoxazole | |
| Isoniazid | |
| TB medication | |
| 34 | Is the stockroom temperature monitored (information on the chart)? |
| 35 | Is the air conditioner working? |
| 36 | Is the temperature less than 25°C? |
| 37 | Is the fridge temperature monitored? |
WHO, World Health Organization; CrAg, Cryptococcal Antigen; ART, antiretroviral treatment; TDF, tenofovir disoproxil fumarate; AZT, azidothymidine; LPV/r, lopinavir or ritonavir; NVP, nevirapine; HB, haemoglobin test; ALT, alanine aminotransferase; TB, tuberculosis; PTB, pulmonary tuberculosis; EPTB, extra-pulmonary tuberculosis; IPT, isoniazid preventive therapy; INH, isoniazid; CPT, cotrimoxazole preventative therapy; HCT, HIV counselling and testing; SCR, serum creatinine; DOB, date of birth, GXP, GeneXpert; AFB, acid fast bacillus; TAT, turnaround time; LPA, Line Probe Assay; ARVs, antiretrovirals.
Reliability of audit tools used to assess the quality of HIV and tuberculosis services.
| Service area audit tools | Number of items | Cronbach’s alpha |
|---|---|---|
| Adult HIV treatment | 15 | 0.8 |
| HIV counselling and testing | 5 | 0.8 |
| TB case finding and management | 10 | 0.9 |
| Pharmacy | 15 | 0.7 |
| Laboratory (original) | 8 | 0.5 |
| Laboratory (revised) | 5 | 0.7 |
Percentage performance in the service areas by districts and cohorts.
| Service area | District A | District B | Both districts | |||
|---|---|---|---|---|---|---|
| 2014 | 2015 | 2014 | 2015 | 2014 | 2015 | |
| Adult ART services | 84.3 | 87.5 | 79.6 | 84.1 | 80.0 | 83.9 |
| HIV counselling and testing | 89.8 | 92.2 | 82.6 | 86.9 | 80.8 | 89.8 |
| TB case findings | 66.7 | 73.8 | 65.2 | 69.2 | 68.9 | 72.4 |
| Laboratory services | 80.4 | 86.8 | 72.4 | 84.6 | 77.0 | 85.6 |
| Pharmacy services | 87.1 | 85.7 | 89.8 | 92.6 | 86.8 | 89.9 |
ART, antiretroviral therapy; TB, tuberculosis.
FIGURE 1Number of healthcare facilities with red-flagged service areas following the 2014 and 2015 audits.
Best and worst performing items in the tuberculosis case finding and management and adult antiretroviral therapy service areas.
| Items | Districts | |
|---|---|---|
| A (%) | B (%) | |
| Line probe assay performed for non-converters | 27.6 | 30.4 |
| Baseline AFB tests result TAT under 48 h | 28.7 | 13.9 |
| Client investigated at 11 weeks | 37.3 | 59.5 |
| GeneXpert® result received under 48 h | 37.6 | 15.1 |
| IPT offered to eligible contacts | 38.8 | 32.9 |
| CrAg performed amongst eligible before ART initiated | 44.5 | 57.9 |
| Patient positive for TB symptoms had appropriate investigations ordered | 52.6 | 34.2 |
| Client diagnosed with GeneXpert® | 97.0 | 95.1 |
| Screened patient recorded at the last visit | 97.1 | 89.5 |
| Patient on TDF, AZT, LPV/r or an NVP-based regimen | 99.6 | 99.4 |
AFB, acid fast bacillus; TAT, turnaround time; IPT, isoniazid prevention therapy; ART, antiretroviral therapy; CrAg, cryptococcal antigen; TB, tuberculosis; TDF, tenofovir disoproxil fumarate; AZT, azidothymidine; LPV/r, lopinavir or ritonavir; NVP, nevirapine.
FIGURE 2Urban and rural quality audit scores in 2014 and 2015 (pre- and post-continuous quality improvement interventions).
Quality assessment items with the highest squared multiple correlation in each service area using the July 2014 baseline audit data.
| Audit tools | Highest loading items and their predictors | Multiple correlation | Communalities % | |
|---|---|---|---|---|
| Adult HIV | Patient who screened positive for TB symptoms had appropriate investigations ordered | 0.8 | 0.9 | |
| Main predictor | Patient screened and recorded at the last visit ( | |||
| HCT | HIV + TB patient started on ART? | 0.6 | 0.8 | |
| Main predictors: ( | HIV + TB patient enrolled into HIV care | |||
| HIV + TB patient taking cotrimoxazole prophylaxis | ||||
| TB case findings and management | Was client investigated at 11 weeks? | 0.8 | 0.8 | |
| Main predictor | Was client investigated at 7 weeks ( | |||
| Pharmacy | Is the information on the bin card maintained and updated for HIV and TB? | - | 0.9 | |
| Main predictors: ( | Bin card for each item in storeroom | |||
| ART in stock | ||||
| Is stock kept on shelves or pallets? | ||||
| Laboratory | Are rejected and lost samples documented in the shipping list/specimen book? | 0.6 | 0.8 | |
| Main predictor | Result received recorded in the shipping list/specimen book? ( | |||
TB, tuberculosis; HCT, HIV counselling and testing; ART, antiretroviral therapy.
, Multiple correlation, this is how well a variable can be predicted by other variables.[19]
%, Communalities, ‘proportion of each variable variance that can be explained by the factors’.[20]
Average district capacity and performance as of July 2014 based on national indicator data set.
| Capacity and performance indicators | District A | District B | ||
|---|---|---|---|---|
| Mean | SD | Mean | SD | |
| PHC utilisation rate (annualised) | 3.4 | 0.4 | 2.6 | 0.2 |
| PHC professional nurse clinical workload | 53.2 | 13.2 | 26.5 | 12.9 |
| PHC doctor clinical workload | 24.5 | 9.2 | 51.3 | 31.3 |
| HIV testing coverage (annualised) | 58.2 | 19.2 | 34.0 | 32.3 |
| HIV prevalence amongst clients tested | 2.4 | 2.5 | 8.6 | 6.6 |
PHC, primary healthcare; SD, standard deviation.
, Indicator definitions and national averages are available in the District Health Barometer 2014–2015.[15]
FIGURE 3Performance of facilities by district health information system indicator pre-and post-continuous quality improvement intervention (April 2014 and October 2015).
Correlations between service area scores and routinely collected national indicator data set.
| National indicator data set | Service area correlation coefficients | ||||
|---|---|---|---|---|---|
| Adult ART | HCT | TB case findings and management | Pharmacy | Laboratory | |
| Median HIV testing coverage (April – July 2014) | 0.14 | 0.05 | |||
| Median HIV prevalence rate (April – July 2014) | −0.09 | 0.01 | |||
| Median HIV + patient screen for TB rate (April – July 2014) | 0.10 | ||||
| Median HIV + initiated on IPT rate (April – July 2014) | 0.13 | 0.16 | 0.15 | 0.10 | |
| Median utilisation rate (April – July 2014) | 0.03 | 0.19 | 0.16 | −0.02 | |
| Median nurse workload (April – July 2014) | 0.04 | 0.08 | 0.03 | −0.02 | |
| Median PHC doctor workload (April – July 2014) | −0.15 | −0.11 | 0.02 | −0.07 | |
Note: Correlations significant at 0.01 level (two-tailed) is in bold.
ART, antiretroviral therapy; HCT, HIV counselling and testing; TB, tuberculosis; IPT, isoniazid prevention therapy; PHC, primary healthcare.
FIGURE 4Average HIV + patient screened for tuberculosis rate by the tuberculosis case finding and management service area quality category.